Your browser doesn't support javascript.
loading
Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial.
Liebers, Nora; Bruch, Peter-Martin; Terzer, Tobias; Hernandez-Hernandez, Miguel; Paramasivam, Nagarajan; Fitzgerald, Donnacha; Altmann, Heidi; Roider, Tobias; Kolb, Carolin; Knoll, Mareike; Lenze, Angela; Platzbecker, Uwe; Röllig, Christoph; Baldus, Claudia; Serve, Hubert; Bornhäuser, Martin; Hübschmann, Daniel; Müller-Tidow, Carsten; Stölzel, Friedrich; Huber, Wolfgang; Benner, Axel; Zenz, Thorsten; Lu, Junyan; Dietrich, Sascha.
Afiliação
  • Liebers N; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Bruch PM; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Terzer T; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hernandez-Hernandez M; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.
  • Paramasivam N; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Germany.
  • Fitzgerald D; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Altmann H; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Roider T; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.
  • Kolb C; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Germany.
  • Knoll M; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Lenze A; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Platzbecker U; Computational Oncology Group, Molecular Precision Oncology Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.
  • Röllig C; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Baldus C; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.
  • Serve H; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
  • Bornhäuser M; University Hospital TU Dresden, Dresden, Germany.
  • Hübschmann D; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Müller-Tidow C; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Stölzel F; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Huber W; Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Benner A; Leipzig University Hospital, Leipzig, Germany.
  • Zenz T; University Hospital TU Dresden, Dresden, Germany.
  • Lu J; Department of Internal Medicine II, University Hospital of Kiel, Kiel, Germany.
  • Dietrich S; Department of Internal Medicine II, University Hospital of Frankfurt Main, Frankfurt am Main, Germany.
Nat Cancer ; 4(12): 1648-1659, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37783805
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Neoplasias Hematológicas Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Nat Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Neoplasias Hematológicas Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Nat Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha